Cutter Law and Almeida Law Group File Lawsuit Alleging Unlawful 'Junk Fees' on Cal Parks' Reservation Site, Oakland, California - May 8, 2025 — Neutral
TYL PRNewsWire — May 08, 2025OAKLAND, Calif. , May 8, 2025 /PRNewswire/ -- Plaintiffs filed a class action lawsuit challenging what they allege are unlawful 'junk fees' charged on the California Department of Parks and Recreation camping reservation website, ReserveCalifornia.com.

Copa Holdings, S.A. (CPA) Q1 2025 Earnings Call Transcript — Neutral
CPA Seeking Alpha — May 08, 2025Copa Holdings, S.A. (NYSE:CPA ) Q1 2025 Earnings Conference Call May 8, 2025 11:00 AM ET Company Participants Daniel Tapia – Director, Investor Relations Pedro Heilbron – Chief Executive Officer Peter Donkersloot – Chief Financial Officer Conference Call Participants Savi Syth – Raymond James Duane Pfennigwerth – Evercore ISI Guilherme Mendes – JPMorgan Stephen Trent – Citi Jens Spiess – Morgan Stanley Rogerio Araujo – Bank of America Michael Linenberg – Deutsche Bank Alberto Valerio – UBS Thomas Fitzgerald – TD Cowen Daniel McKenzie – Seaport Global Operator Ladies and gentlemen, thank you for standing by.

Zoetis: Solid Q1 Results And A Weaker Dollar Provide Support (Upgrade) — Neutral
ZTS Seeking Alpha — May 08, 2025Zoetis shares have underperformed, losing 8% over the past year, but recent solid earnings and guidance suggest shares are nearer to fair value, shifting my stance from "sell" to "hold.". The company reported $1.48 EPS, beating estimates, with 9% organic growth despite foreign exchange headwinds; US dollar weakness should boost future results. Zoetis maintains a strong balance sheet, with $1.7 billion cash and $6.6 billion debt, supporting shareholder returns through buybacks and dividends.

Cogent Communications Holdings, Inc. (CCOI) Q1 2025 Earnings Call Transcript — Neutral
CCOI Seeking Alpha — May 08, 2025Cogent Communications Holdings, Inc. (NASDAQ:CCOI ) Q1 2025 Earnings Conference Call May 8, 2025 8:30 AM ET Company Participants Dave Schaeffer - Chairman & Chief Executive Officer Tad Weed - Chief Financial Officer Conference Call Participants Greg Williams - TD Cowen Alex Waters - Bank of America Walter Piecyk - LightShed Chris Scholl - UBS Nick Del Deo - MoffettNathanson Michael Rollins - Citi Tim Horan - Oppenheimer Operator Good morning and welcome to Cogent Communications Holdings First Quarter 2025 Earnings Conference Call. As a reminder, this conference call is being recorded and it will be available for replay at …

Donation in New Jersey region follows Red Cross response to Ocean County wildfire HOLMDEL, N.J. , May 8, 2025 /PRNewswire/ -- The FirstEnergy Foundation has donated $25,000 to the American Red Cross to support its efforts to offer disaster assistance to families living in communities served by FirstEnergy Corp. (NYSE: FE) electric company Jersey Central Power & Light (JCP&L).

Myriad Genetics, Inc. (MYGN) Investors Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation — Neutral
MYGN Business Wire — May 08, 2025BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Myriad Genetics, Inc. (“Myriad” or the “Company”) (NASDAQ: MYGN) investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN MYRIAD GENETICS, INC. (MYGN), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. Contact the Law Offices of Howard G. Smith to discuss your legal rights b.

Franklin Electric Announces Appointment of Jennifer L. Sherman as Chairperson; Mark Carano Elected to be a Director of the Company — Neutral
FELE GlobeNewsWire — May 08, 2025FORT WAYNE, Ind., May 08, 2025 (GLOBE NEWSWIRE) -- The Board of Directors of Franklin Electric Co., Inc. (NASDAQ: FELE) has elected Jennifer L. Sherman, President and Chief Executive Officer of Federal Signal Corporation, as Chairperson effective as of May 2, 2025 for a term expiring at the 2026 Annual Meeting of Shareholders. Ms. Sherman has been a Director of the Company since 2015. Joe Ruzynski, the Company's Chief Executive Officer, commented: “I want to congratulate Jennifer on her election as Chairperson of Franklin Electric. She knows the Company well, having served on our Board of Directors for 10 years, …

Ormat Technologies, Inc. (ORA) Q1 2025 Earnings Call Transcript — Neutral
ORA Seeking Alpha — May 08, 2025Ormat Technologies, Inc. (NYSE:ORA ) Q1 2025 Earnings Call May 8, 2025 9:00 AM ET Company Participants Josh Carroll - Investor Relations Doron Blachar - Chief Executive Officer Assi Ginzburg - Chief Financial Officer Smadar Lavi - Vice President, Investor Relations and ESG Planning and Reporting Conference Call Participants Justin Clare - ROTH Capital Michael Fairbanks - JPMorgan Andre Adams - Oppenheimer David Anderson - Barclays Ben Kallo - Baird Operator Good morning and welcome to the Ormat Technologies' First Quarter 2025 Earnings Conference Call. [Operator Instructions] Please note that this event is being recorded.

CIVI DEADLINE: Civitas Resources, Inc. Investors That Suffered Losses Are Notified of the July 1 Class Action Deadline — Neutral
CIVI Accesswire — May 08, 2025NEW YORK CITY, NY / ACCESS Newswire / May 8, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Civitas Resources, Inc. (NYSE:CIVI) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Civitas you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/civitas-resources-inc.

West Pharmaceutical Services, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - WST — Neutral
WST Accesswire — May 08, 2025NEW YORK, NY / ACCESS Newswire / May 8, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=147595&wire=1 or contact Joseph E. Levi, Esq.

Viatris Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before June 3, 2025 to Discuss Your Rights - VTRS — Neutral
VTRS Accesswire — May 08, 2025NEW YORK, NY / ACCESS Newswire / May 8, 2025 / If you suffered a loss on your Viatris Inc. (NASDAQ:VTRS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/viatris-inc-lawsuit-submission-form-2?prid=147596&wire=1 or contact Joseph E. Levi, Esq.

Zynex, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before May 19, 2025 to Discuss Your Rights – ZYXI — Neutral
ZYXI Accesswire — May 08, 2025NEW YORK, NY / ACCESS Newswire / May 8, 2025 / If you suffered a loss on your Zynex, Inc. (NASDAQ:ZYXI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/zynex-inc-lawsuit-submission-form?prid=147599&wire=1 or contact Joseph E. Levi, Esq.

Class Action Filed Against Actinium Pharmaceuticals, Inc. (ATNM) - May 27, 2025 Deadline to Join - Contact Levi & Korsinsky — Neutral
ATNM Accesswire — May 08, 2025NEW YORK, NY / ACCESS Newswire / May 8, 2025 / If you suffered a loss on your Actinium Pharmaceuticals, Inc. (NYSE:ATNM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/actinium-lawsuit-submission-form?prid=147597&wire=1 or contact Joseph E. Levi, Esq.

These yield-rich stocks aren't typical dividend plays. Why they're worth the risk. — Positive
AFCG REFI Market Watch — May 08, 2025Cannabis-sector lenders offer attractive upside potential.

Comcast Growth Steps Will Take 'A Minimum Of Several Quarters' To Generate Returns: Analyst — Neutral
CMCSA Benzinga — May 08, 2025BofA Securities analyst Jessica Reif Ehrlich maintained a Neutral rating on Comcast Corp CMCSA with a price forecast of $38 on Thursday.

Golden Ocean Group Limited (the “Company”) advises that the 2025 Annual General Meeting of the Shareholders of the Company was held on 8 May 2025 at 08:30 hrs, at Hamilton Princess and Beach Club, 76 Pitts Bay Road, Hamilton HMCX, Bermuda. The audited consolidated financial statements for the Company for the year ended December 31, 2024 were presented to the Meeting.

KRG's acquisition of a 52% interest in Legacy West with GIC aligns with broader real estate trends and offers significant future rent growth potential. Q1 financials were strong, with a 6.9% YoY revenue increase and 10% YoY core FFO per share growth. Potential risks include rising bad debt expenses and interest costs, with a 100bps rate increase potentially adding ~$7.5 million to annual interest expenses.

Kimbell Royalty Partners, LP Common Units (KRP) Q1 2025 Earnings Call Transcript — Neutral
KRP Seeking Alpha — May 08, 2025Kimbell Royalty Partners, LP Common Units (NYSE:KRP ) Q1 2025 Earnings Conference Call May 8, 2025 11:00 AM ET Company Participants Rick Black - Investor Relations Bob Ravnaas - Chairman & Chief Executive Officer Davis Ravnaas - President & Chief Financial Officer Matt Daly - Chief Operating Officer Conference Call Participants Tim Rezvan - KeyBanc Capital Markets John Annis - Texas Capital Paul Diamond - Citibank Noah Hungness - Bank of America Operator Greetings, and welcome to the Kimbell Royalty Partners First Quarter Earnings Conference Call. At this time all participants are in a listen-only mode.

Vir Biotechnology: Tobevibart Combination Pushing Forward For Needed HDV Treatment — Positive
VIR Seeking Alpha — May 08, 2025Vir Biotechnology, Inc.'s phase 3 ECLIPSE program for HDV, leveraging tobevibart and elebsiran, shows promise based on positive phase 2 SOLSTICE study results. The global hepatitis D market size is projected to surpass $1.05 billion by 2034. VIR-5518 and VIR-5500 are dual-masked HER2 and PSMA T-cell engagers being developed to target solid tumors; The current status of these candidates is that dose-escalation for both are ongoing.
